$8.910
-0.069 (-0.78%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ASBP por análisis de gráficos similares
Alphio's ASBP stock price prediction model matches the current Aspire Biopharma Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.05 (+1.52%). The 1-week path is $9.07 (+1.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Aspire Biopharma Holdings Inc?
PowerUp Acquisition Corp is not a good buy right now due to its significant decline in value, with a year-to-date change of -94.82% and a one-year change of -98.77%. Although the recent 5-day change is +6.78%, the overall trend remains negative, and the RSI is at 73.071, indicating potential overbought conditions. The main risk is its current financial instability, highlighted by a negative net income of -1,268,142 USD in Q2 2026 and a gross margin of -47.68%.
ASBP cerró en $8.91 el Tuesday, tras bajar -0.78%
Aspire Biopharma Holdings Inc (ASBP) last closed at $8.91, losing -0.78%. These facts feed the 1-day and 1-week ASBP price prediction above.
Factores de la previsión
Los factores de la previsión de Aspire Biopharma Holdings Inc (ASBP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ASBP, ordenadas por similitud.
Análisis de estacionalidad de ASBP
Historically the probability of a positive September return for ASBP is 47.62%. November offers the highest probability of a positive month at 51.28%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ASBP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $0.34 | $0.39 | $0.41 | -95.67% |
| Oct 2026 | $0.33 | $0.36 | $0.41 | -95.95% |
| Nov 2026 | $0.38 | $0.41 | $0.44 | -95.41% |
| Dec 2026 | $0.32 | $0.38 | $0.44 | -95.69% |
En 2026, se proyecta que Aspire Biopharma Holdings Inc (ASBP) oscile entre $0.32 y $0.44.
Previsión mensual de Aspire Biopharma Holdings Inc para 2026
En Sep de 2026, se proyecta que Aspire Biopharma Holdings Inc promedie $0.39, con un mínimo de $0.34 y un máximo de $0.41.
En Oct de 2026, se proyecta que Aspire Biopharma Holdings Inc promedie $0.36, con un mínimo de $0.33 y un máximo de $0.41.
En Nov de 2026, se proyecta que Aspire Biopharma Holdings Inc promedie $0.41, con un mínimo de $0.38 y un máximo de $0.44.
En Dec de 2026, se proyecta que Aspire Biopharma Holdings Inc promedie $0.38, con un mínimo de $0.32 y un máximo de $0.44.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.